These include IDH-wildtype glioblastoma (GBM), IDH-mutant astrocytoma, diffuse midline glioma (DMG)—typically characterized by H3K27 alterations—and low-grade gliomas. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).